首页/数据集/Evolvement of Chromosomal instability in drug-resistance by BUB1B and circBUB1B_544aa in multiple myeloma

Evolvement of Chromosomal instability in drug-resistance by BUB1B and circBUB1B_544aa in multiple myeloma

Name: Evolvement of Chromosomal instability in drug-resistance by BUB1B and circBUB1B_544aa in multiple myeloma
Creator: Nanjing University of Chinese Medicine
Published: 2021-03-04T17:24:52+08:00

integrated proteome resources2026-02-07 收录

多发性骨髓瘤

药物抗性

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0002874000 数据链接链接失效反馈

官方服务：

资源简介：

Evolvement of Chromosomal instability in drug-resistance by BUB1B and circBUB1B_544aa in multiple myeloma

应用场景：

提供机构：

Nanjing University of Chinese Medicine

创建时间：

2021-03-04

多发性骨髓瘤

代谢组学

Conducted nontargeted metabolomics analysis of MM patients and normal controls (NC) using ultra-high-performance liquid chromatography (UHPLC) combined with quadrupole time-of-flight mass spectrometry

DataCite Commons2025-04-01 更新90

Identification of novel combined biomarkers in the diagnosis of multiple myeloma

多发性骨髓瘤

生物标志物

Multiple myeloma (MM) is a haematological malignant disease with a clonal proliferation of plasma cells, and timely surveillance is helpful to improve the survival rate of patients with MM. However, t

DataCite Commons2024-02-13 更新60

Tissue-resident macrophages promote multiple myeloma early dissemination and progression via IL-6 and TNFa. Tissue-resident macrophages promote multiple myeloma early dissemination and progression via IL-6 and TNFa

肿瘤免疫微环境

多发性骨髓瘤

Multiple myeloma (MM) is a plasma cell malignancy characterized by the presence of multiple foci in the skeleton. These distinct tumor foci indicate cycles of tumor growth and dissemination that seed

NIAID Data Ecosystem40

MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells. Homo sapiens

多发性骨髓瘤

基因表达调控

Multiple myeloma (MM) is characterized by recurrent chromosomal translocations. The translocation t(4;14)(p16;q32) is one of the most common translocation in MMs, affecting 15% of patients, and is ass

NIAID Data Ecosystem70

Additional file 7: of PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

多发性骨髓瘤

基因表达

Table S7. 31 EPZ-6438 + combo upregulated genes (XLSX 11 kb)

NIAID Data Ecosystem50